Overview
Anomalous origin of coronary artery from the pulmonary artery (ACAPA) is a rare congenital heart defect in which one or both coronary arteries arise from the pulmonary artery instead of the aorta. The most common and well-known subtype is anomalous left coronary artery from the pulmonary artery (ALCAPA), also known as Bland-White-Garland syndrome. Less frequently, the right coronary artery (ARCAPA) or both coronary arteries may originate from the pulmonary artery. Because the pulmonary artery carries deoxygenated blood at lower pressure, the affected coronary artery delivers inadequate oxygen to the heart muscle (myocardium), leading to myocardial ischemia and potentially life-threatening complications. In infants with ALCAPA, symptoms typically develop within the first few months of life as pulmonary vascular resistance drops after birth, reducing perfusion pressure in the anomalous coronary artery. Key clinical features include heart failure, poor feeding, irritability (especially during feeding or crying due to angina-like chest pain), excessive sweating, pallor, and failure to thrive. Left ventricular dysfunction and mitral regurgitation are common findings. Without treatment, ALCAPA carries a high mortality rate in infancy, with up to 90% of untreated infants dying within the first year of life. Some patients develop extensive collateral circulation between the right and left coronary systems, which may allow survival into childhood or adulthood, sometimes presenting with exercise intolerance, arrhythmias, or sudden cardiac death. ARCAPA tends to have a milder presentation and may be discovered incidentally. The primary treatment for ACAPA is surgical correction, which aims to establish a two-coronary-artery system with both arteries arising from the aorta. The most commonly performed procedure is direct reimplantation of the anomalous coronary artery into the aorta (the Takeuchi procedure or direct transfer technique). Early surgical intervention significantly improves outcomes, and most patients who undergo successful repair have good long-term prognosis with recovery of left ventricular function. Mitral valve repair may be performed concurrently if significant regurgitation is present. Lifelong cardiac follow-up is recommended to monitor for potential complications including coronary artery stenosis, arrhythmias, and residual ventricular dysfunction.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Anomalous origin of coronary artery from the pulmonary artery.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Anomalous origin of coronary artery from the pulmonary artery at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Anomalous origin of coronary artery from the pulmonary artery.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Anomalous origin of coronary artery from the pulmonary artery.
Community
No community posts yet. Be the first to share your experience with Anomalous origin of coronary artery from the pulmonary artery.
Start the conversation →Latest news about Anomalous origin of coronary artery from the pulmonary artery
No recent news articles for Anomalous origin of coronary artery from the pulmonary artery.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Anomalous origin of coronary artery from the pulmonary artery
What is Anomalous origin of coronary artery from the pulmonary artery?
Anomalous origin of coronary artery from the pulmonary artery (ACAPA) is a rare congenital heart defect in which one or both coronary arteries arise from the pulmonary artery instead of the aorta. The most common and well-known subtype is anomalous left coronary artery from the pulmonary artery (ALCAPA), also known as Bland-White-Garland syndrome. Less frequently, the right coronary artery (ARCAPA) or both coronary arteries may originate from the pulmonary artery. Because the pulmonary artery carries deoxygenated blood at lower pressure, the affected coronary artery delivers inadequate oxygen
How is Anomalous origin of coronary artery from the pulmonary artery inherited?
Anomalous origin of coronary artery from the pulmonary artery follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Anomalous origin of coronary artery from the pulmonary artery typically begin?
Typical onset of Anomalous origin of coronary artery from the pulmonary artery is infantile. Age of onset can vary across affected individuals.